2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice …

FLJ Visseren, F Mach, YM Smulders… - European heart …, 2021 - academic.oup.com
Atherosclerotic cardiovascular (CV) disease (ASCVD) incidence and mortality rates are
declining in many countries in Europe, but it is still a major cause of morbidity and mortality …

Cardiotoxicity of anthracyclines

D Cardinale, F Iacopo, CM Cipolla - Frontiers in cardiovascular …, 2020 - frontiersin.org
Cardiotoxicity is a feared side effect that may limit the clinical use of anthracyclines. It may
indeed affect the quality of life and survival of patients with cancer, regardless of oncological …

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …

AR Lyon, T Lopez-Fernandez, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

[HTML][HTML] Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations

G Curigliano, D Lenihan, M Fradley, S Ganatra… - Annals of …, 2020 - Elsevier
Cancer and cardiovascular (CV) disease are the most prevalent diseases in the developed
world. Evidence increasingly shows that these conditions are interlinked through common …

Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E …

J Čelutkienė, R Pudil… - European journal of …, 2020 - Wiley Online Library
Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …

Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction

E Potter, TH Marwick - JACC: Cardiovascular Imaging, 2018 - jacc.org
Left ventricular (LV) ejection fraction (LVEF) is a simple measure of global systolic function
that pervades the risk evaluation and management of many cardiovascular diseases …

Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: a systematic review and meta …

EK Oikonomou, DG Kokkinidis, PN Kampaktsis… - JAMA …, 2019 - jamanetwork.com
Importance Echocardiographic left ventricular global longitudinal strain (GLS) detects early
subclinical ventricular dysfunction and can be used in patients receiving potentially …

Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline

SH Armenian, C Lacchetti, A Barac, J Carver… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Cardiac dysfunction is a serious adverse effect of certain cancer-directed therapies
that can interfere with the efficacy of treatment, decrease quality of life, or impact the actual …

Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1

HM Chang, R Moudgil, T Scarabelli… - Journal of the American …, 2017 - jacc.org
Modern cancer therapy has successfully cured many cancers and converted a terminal
illness into a chronic disease. Because cancer patients often have coexisting heart …

A test in context: myocardial strain measured by speckle-tracking echocardiography

P Collier, D Phelan, A Klein - Journal of the American College of …, 2017 - jacc.org
Strain-based imaging techniques (and specifically speckle-tracking echocardiography) have
been shown to have clinical utility in a variety of settings. This technique is being embraced …